1 / 11

Mucormycosis Market Potential Growth, Analysis of Top Key Players

The emergence of the COVID-19 pandemic along with the increasing cases of blood cancers and diabetes will be the main factors for the growth of the global market during the forecast period. Organ and bone marrow transplantation along with increasing immune-competent patients due to the conditions like HIV will also boost the growth of the global market.

priyanka1988
Download Presentation

Mucormycosis Market Potential Growth, Analysis of Top Key Players

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mucormycosis Market Market Size Worth $616.1 Million By 2028 | CAGR: 3.4%

  2. Mucormycosis Market Size Worth $616.1 Million By 2028 “According to Polaris Market Research report, Mucormycosis market is witnessing a major transformation and is projected to reach $616.1 Million By 2028 registering a CAGR of 3.4% during the forecast period 2021 to 2028.” The global Mucormycosis market growth is driven by some of the key factors such as growing awareness among consumers, increasing investments by private-public organizations, and favorable government policies. Additionally, many prominent players present in the market are concentrating on the adoption of new technology and product launches to obtain a competitive edge, which in turn contributes to the Mucormycosis market growth. The regulatory agencies are also playing a key role as the major driving force for the market, by safeguarding the quality of product/service offerings as well as accelerating new approvals. Mucormycosis Market Report Scope: The study provides a comprehensive view of the Mucormycosis market by segmenting it based on Diagnosis, Treatment, End-Use and region. All the segments of the market have been thoroughly analyzed based on present and future trends. The research report has identified the key segments contributing most to the Mucormycosis market growth in terms of revenue along with other vital factors impacting the market dynamics. Further, the market analysis covered in the report also answers the imperative question for new entrants and existing players operating in the market. Browse Detailed Research Report On Mucormycosis Market Analysis: https://www.polarismarketresearch.com/industry-analysis/mucormycosis-market - 2 -

  3. Mucormycosis Market Size Worth $616.1 Million By 2028 By Diagnosis By Treatment By End-Use By Region •Computed Tomography (CT) •Magnetic Resonance Imaging (MRI) •Tissue Biopsy •Others •Surgery •Antifungal Drugs •Amphotericin B Therapy •Others •Hospitals & Clinics •Medical Institutes •Research Organization •Others •North America (U.S., Canada) •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) Impact Analysis of COVID-19 on Mucormycosis Market The global Mucormycosis market is anticipated to continue its growth amid the covid-19 pandemic. After giving insightful information on market behavior pre and post COVID-19 pandemic, the report also sheds light on the key strategic moves to overcome the adverse impact of COVID-19 on business and turn the positive impact into a lucrative opportunity. Regional Outlook The regional market of North America is witnessing a significant rise in the growth rate and is expected to account for the largest market share over the forecast period. The market is flourishing as a result of its increasing application scope and ample availability of vital resources. During the forecast period, the Asia Pacific region is estimated to garner the highest CAGR for the Mucormycosis market, owing to the presence of several leading local and international players operating in the regional market. Gain access to our latest research report that includes a detailed analysis of the COVID-19 pandemic influencing the Mucormycosis market in different regions and how market players devising effective strategies to mitigate the effect of the pandemic: https://www.polarismarketresearch.com/industry- analysis/mucormycosis-market/speak-to-analyst - 3 -

  4. Mucormycosis Market Size Worth $616.1 Million By 2028 Competitive Landscape Leading companies holding significant market shares in the Mucormycosis market are analyzed considering their market shares, growth rates, market revenue, business strategies, and latest developments. Recent events for these major companies such as acquisitions, research initiatives, technological advancements, new solution/product launches, and geographical expansions considered in finalizing their position in the market. According to Polaris Market Research, the leading players with a noteworthy share in the Mucormycosis market include Biocon Limited, Abbott Laboratories, Cadila Pharmaceuticals Limited, F. Hoffman La Roche, Novartis AG, Merck Sharp and Dohme, Bristol Myers Squibb, Mylan Labs, Bayer AG, Sanofi, Lonza Group, Johnson & Johnson, Gilead Sciences and Pfizer Inc. Request for sample: https://www.polarismarketresearch.com/industry-analysis/mucormycosis- market/request-for-sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Mining 3.2.1 Primary Sources 3.2.2 Secondary Sources 4.Mucormycosis Market Insights 4.1.Mucormycosis – Industry snapshot 4.2.Mucormycosis Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. Surge in fungal infections 4.2.1.2. Extensive use of immunosuppressants and steroids - 4 -

  5. Mucormycosis Market Size Worth $616.1 Million By 2028 4.2.2.Restraints and Challenges 4.2.2.1. Slow diagnosis rate 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Mucormycosis Market Industry trends 5.Mucormycosis Market Assessment by Diagnosis 5.1.Key Findings 5.2.Introduction 5.2.1.Global Mucormycosis Market, By Diagnosis, 2016 – 2028 (USD Million) 5.3.Computed Tomography (CT) 5.3.1.Global Mucormycosis Market, by Computed Tomography (CT), By Region, 2016- 2028 (USD Million) 5.4.Magnetic Resonance Imaging (MRI) 5.4.1.Global Mucormycosis Market, by Magnetic Resonance Imaging (MRI), by Region, 2016- 2028 (USD Million) 5.5.Tissue Biopsy 5.5.1.Global Mucormycosis Market, by Tissue Biopsy, by Region, 2016- 2028 (USD Million) 5.6.Others 5.6.1.Global Mucormycosis Market, by Others, by Region, 2016- 2028 (USD Million) 6.Global Mucormycosis Market, by Treatment 6.1.Key Findings 6.2.Introduction 6.2.1.Global Mucormycosis Market, By Treatment, 2016 – 2028 (USD Million) 6.3.Surgery 6.3.1.Global Mucormycosis Market, by Surgery, By Region, 2016- 2028 (USD Million) 6.4.Antifungal Drugs 6.4.1.Global Mucormycosis Market, by Antifungal Drugs, by Region, 2016- 2028 (USD Million) 6.5.Amphotericin B Therapy 6.5.1.Global Mucormycosis Market, by Amphotericin B Therapy, by Region, 2016- 2028 (USD Million) - 5 -

  6. Mucormycosis Market Size Worth $616.1 Million By 2028 6.6.Others 6.6.1.Global Mucormycosis Market, by Others, by Region, 2016- 2028 (USD Million) 7.Mucormycosis Market Assessment by End Use 7.1.Key Findings 7.2.Introduction 7.2.1.Global Mucormycosis Market, By End Use, 2016 – 2028 (USD Million) 7.3.Hospitals & Clinics 7.3.1.Global Mucormycosis Market, by Hospitals & Clinics, by Region, 2016- 2028 (USD Million) 7.4.Medical Institutes 7.4.1.Global Mucormycosis Market, by Medical Institutes, by Region, 2016- 2028 (USD Million) 7.5.Research Organization 7.5.1.Global Mucormycosis Market, by Research Organization, by Region, 2016- 2028 (USD Million) 7.6.Others 7.6.1.Global Mucormycosis Market, by Others, by Region, 2016- 2028 (USD Million) 8.Mucormycosis Market Assessment by Geography 8.1.Key findings 8.2.Introduction 8.2.1.Mucormycosis Market Assessment, By Geography, 2016- 2028 (USD Million) 8.3.Mucormycosis Market – North America 8.3.1.North America: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.3.2.North America: Mucormycosis Market, By Treatment, 2016 - 2028 (USD Million) 8.3.3.North America: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.3.4.Mucormycosis Market – U.S. 8.3.4.1. U.S.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.3.4.2. U.S.: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.3.4.3. U.S.: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.3.5.Mucormycosis Market – Canada 8.3.6.Canada.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.3.7.Canada: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.3.8.Canada: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.Mucormycosis Market – Europe 8.4.1.Europe.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.2.Europe: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.3.Europe: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) - 6 -

  7. Mucormycosis Market Size Worth $616.1 Million By 2028 8.4.4.Mucormycosis Market – UK 8.4.4.1. UK.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.4.2. UK: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.4.3. UK: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.5.Mucormycosis Market – France 8.4.5.1. France.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.5.2. France: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.5.3. France: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.6.Mucormycosis Market – Germany 8.4.6.1. Germany.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.6.2. Germany: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.6.3. Germany: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.7.Mucormycosis Market – Italy 8.4.7.1. Italy.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.7.2. Italy: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.7.3. Italy: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.8.Mucormycosis Market – Spain 8.4.8.1. Spain.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.8.2. Spain: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.8.3. Spain: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.9.Mucormycosis Market – Netherlands 8.4.9.1. Netherlands.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.9.2. Netherlands: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.9.3. Netherlands: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.4.10.Mucormycosis Market – Austria 8.4.10.1.Austria.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.4.10.2.Austria: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.4.10.3.Austria: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.5.Mucormycosis Market – Asia-Pacific 8.5.1.Asia Pacific.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.5.2.Asia-pacific: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.5.3.Asia-pacific: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.5.4.Mucormycosis Market – China 8.5.4.1. China.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.5.4.2. China: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.5.4.3. China: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.5.5.Mucormycosis Market – India 8.5.5.1. India.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) - 7 -

  8. Mucormycosis Market Size Worth $616.1 Million By 2028 8.5.5.2. 8.5.5.3. 8.5.6.Mucormycosis Market – Malaysia 8.5.6.1. Malaysia.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.5.6.2. Malaysia: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.5.6.3. Malaysia: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.5.7.Mucormycosis Market – Japan 8.5.7.1. Japan.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.5.7.2. Japan: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.5.7.3. Japan: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.5.8.Mucormycosis Market – Indonesia 8.5.8.1. Indonesia.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.5.8.2. Indonesia: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.5.8.3. Indonesia: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.5.9.Mucormycosis Market – South Korea 8.5.9.1. South Korea.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.5.9.2. South Korea: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.5.9.3. South Korea: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.6.Mucormycosis Market – Middle East & Africa 8.6.1.Middle East & Africa.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.6.2.Middle East & Africa: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.6.3.Middle East & Africa: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.6.4.Mucormycosis Market – Saudi Arabia 8.6.4.1. Saudi Arabia.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.6.4.2. Saudi Arabia: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.6.4.3. Saudi Arabia: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.6.5.Mucormycosis Market – UAE 8.6.5.1. UAE.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.6.5.2. UAE: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.6.5.3. UAE: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.6.6.Mucormycosis Market – Israel 8.6.6.1. Israel.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.6.6.2. Israel: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.6.6.3. Israel: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) India: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) India: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) - 8 -

  9. Mucormycosis Market Size Worth $616.1 Million By 2028 8.6.7.Mucormycosis Market – South Africa 8.6.7.1. South Africa.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.6.7.2. South Africa: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.6.7.3. South Africa: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.7.Mucormycosis Market – Latin America 8.7.1.Latin America.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.7.2.Latin America: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.7.3.Latin America: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.7.4.Mucormycosis Market – Mexico 8.7.4.1. Mexico: Mucormycosis Market, By Species, 2016- 2028 (USD Million) 8.7.4.2. Mexico.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.7.4.3. Mexico: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.7.4.4. Mexico: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.7.5.Mucormycosis Market – Brazil 8.7.5.1. Brazil.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.7.5.2. Brazil: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.7.5.3. Brazil: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 8.7.6.Mucormycosis Market – Argentina 8.7.6.1. Argentina.: Mucormycosis Market, By Diagnosis, 2016- 2028 (USD Million) 8.7.6.2. Argentina: Mucormycosis Market, By Treatment, 2016- 2028 (USD Million) 8.7.6.3. Argentina: Mucormycosis Market, By End Use, 2016- 2028 (USD Million) 9.Competitive Landscape 9.1.Expansion and Acquisition Analysis 9.1.1.Expansion 9.1.2.Acquisition 9.2.Partnerships/Collaborations/Agreements/Exhibitions 10.Company Profiles 10.1. Biocon Limited 10.1.1.Company Overview 10.1.2.Financial Performance 10.1.3.Product Benchmarking 10.1.4.Recent Development 10.2. Abbott Laboratories 10.2.1.Company Overview 10.2.2.Financial Performance 10.2.3.Product Benchmarking 10.2.4.Recent Development - 9 -

  10. Mucormycosis Market Size Worth $616.1 Million By 2028 10.3. Cadila Pharmaceuticals Limited 10.3.1.Company Overview 10.3.2.Financial Performance 10.3.3.Product Benchmarking 10.3.4.Recent Development 10.4. F. Hoffman La Roche 10.4.1.Company Overview 10.4.2.Financial Performance 10.4.3.Product Benchmarking 10.4.4.Recent Development 10.5. Novartis AG 10.5.1.Company Overview 10.5.2.Financial Performance 10.5.3.Product Benchmarking 10.5.4.Recent Development 10.6. Merck & Co., Inc. 10.6.1.Company Overview 10.6.2.Financial Performance 10.6.3.Product Benchmarking 10.6.4.Recent Development 10.7. Mylan Labs 10.7.1.Company Overview 10.7.2.Financial Performance 10.7.3.Product Benchmarking 10.7.4.Recent Development 10.8. Pfizer Inc. 10.8.1.Company Overview 10.8.2.Financial Performance 10.8.3.Product Benchmarking 10.8.4.Recent Development 10.9. Bristol Myers Squibb 10.9.1.Company Overview 10.9.2.Financial Performance 10.9.3.Product Benchmarking 10.9.4.Recent Development 10.10. Bayer AG 10.10.1. 10.10.2. 10.10.3. 10.10.4. 10.11. Lonza Group 10.11.1. 10.11.2. Company Overview Financial Performance Product Benchmarking Recent Development Company Overview Financial Performance - 10 -

  11. Mucormycosis Market Size Worth $616.1 Million By 2028 10.11.3. 10.11.4. 10.12. 10.12.1. 10.12.2. 10.12.3. 10.12.4. 10.13. 10.13.1. 10.13.2. 10.13.3. 10.13.4. 10.14. 10.14.1. 10.14.2. 10.14.3. 10.14.4. Product Benchmarking Recent Development Sanofi Company Overview Financial Performance Product Benchmarking Recent Development Johnson & Johnson Company Overview Financial Performance Product Benchmarking Recent Development Gilead Sciences Company Overview Financial Performance Product Benchmarking Recent Development Access Press Release on Mucormycosis Market: https://www.polarismarketresearch.com/press- releases/mucormycosis-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 11 -

More Related